Congo vs Madagascar: Share of people with HIV who receive antiretroviral therapy
Congo
34.0%
in 2024
Madagascar
29.0%
in 2024
Congo rank
135th
Madagascar rank
136th
Share of people with HIV who receive antiretroviral therapy over time
- Congo
- Madagascar
How they compare
Congo currently reports 34.0% against 29.0% in Madagascar, a difference of 5.0%.
That makes Congo's figure about 1.2 times Madagascar's.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Madagascar ahead.
Congo ranks 135th and Madagascar ranks 136th of 143 countries.
Congo has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Congo | Madagascar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.7% | 0.4% | 3.3% | Congo |
| 2010s | 19.7% | 3.6% | 16.1% | Congo |
| 2020s | 28.2% | 18.8% | 9.4% | Congo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of people with hiv who receive antiretroviral therapy, Congo or Madagascar?
- Congo, at 34.0% against 29.0% in Madagascar as of 2024.
- What is the difference in share of people with hiv who receive antiretroviral therapy between Congo and Madagascar?
- 5.0%, with Congo ahead.
- How many years of comparable data are there for Congo and Madagascar?
- 25 years are reported by both, from 2000 to 2024.
- How do Congo and Madagascar rank globally for share of people with hiv who receive antiretroviral therapy?
- Congo ranks 135th and Madagascar ranks 136th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of people with HIV who receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.